Company news

Tango Therapeutics, Inc. news in 2021

Tango Therapeutics, Inc.'s news releases, calls and decks from 2021, newest first.

View company

Tango Therapeutics to Participate in the Jefferies London Healthcare Conference

November 10, 2021

Tango Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Highlights

November 8, 2021

Tango Therapeutics Announces Appointment of Dr. Marc Rudoltz as Chief Medical Officer and Doug Barry as General Counsel

October 31, 2021

Tango Therapeutics Announces Presentation of Preclinical Data on Lead Program and Discovery Platform in Five Abstracts Accepted at AACR-NCI-EORTC 2021

September 29, 2021

Tango Therapeutics Debuts as Publicly Traded Precision Oncology Company Focused on the Next Generation of Targeted Cancer Therapies

August 9, 2021

Tango Therapeutics and BCTG Acquisition Corp. Announce Merger Agreement to Create Publicly Listed Precision Medicine Company Focused on the Next Generation of Targeted Cancer Therapies

April 13, 2021

Decks in 2021